Código QR

Hexaraphane as a potential therapeutic strategy for tauopathies

Alzheimer's disease (AD) is characterized by pathological hyperphosphorylation of TAU protein, leading to neurofibrillary tangle formation, synaptic dysfunction, neuroinflammation, and neuronal loss. Hexaraphane (6-(methylsulfinyl) hexyl isothiocyanate; HXN), a bioactive compound derived from Wasabi...

Descrición completa

Gardado en:
Principais autores: Ángel Juan García-Yagüe, Daniel Carnicero-Senabre, Ángel Núñez, Raffaela Cipriani, Estibaliz Capetillo-Zarate, Maribel Escoll, Isao Okunishi, Ana I. Rojo, Antonio Cuadrado
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2026-05-01
Series:Redox Biology
Assuntos:
NRF2
Hexaraphane
Tauopathies
PP2A
Neurodegeneration
Alzheimer's disease
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2213231726001059
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares